Indeed, the PNPLA3 rs738409 variant is reported as a major determinant of hepatic fat content and was found to be significantly associated with NAFLD in the overall population [2,8,9,38]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.